EAACI Congress 2023 Back

Jenny Goodman is a Senior Development Scientist at Allergy Therapeutics (UK) Ltd. She joined Allergy Therapeutics back in 2019 following the successful completion of her PhD at the University of Warwick, which focused on using mass spectrometry to investigate protein interactions. Jenny has continued to focus on mass spectrometry, alongside other biochemistry techniques, developing methods within a regulated environment to support products for the treatment of allergies.